Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study

P. Barbanti, C. Aurilia, G. Egeo, L. Fofi, S. Cevoli, B. Colombo, M. Filippi, F. Frediani, F. Bono, L. Grazzi, A. Salerno, B. Mercuri, A. Carnevale, C. Altamura, F. Vernieri

Research output: Contribution to journalArticlepeer-review

Cite this